Cambridge Investment Research Advisors’s Neogen NEOG Stock Holding History

Cambridge Investment Research Advisors’s Portfolio NEOG Stock Details NEOG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-13,199	Closed	-$222K	–	3562
2024 Q3	$222K	Sell	13,199 -1,464	-10%	-$24.1K	﹤0.01%	3065
2024 Q2	$229K	Sell	14,663 -2,597	-15%	-$36.1K	﹤0.01%	2925
2024 Q1	$272K	Sell	17,260 -2,419	-12%	-$40.5K	﹤0.01%	2779
2023 Q4	$396K	Sell	19,679 -28,588	-59%	-$484K	﹤0.01%	2381
2023 Q3	$895K	Sell	48,267 -2,727	-5%	-$59.4K	﹤0.01%	1647
2023 Q2	$1.11M	Sell	50,994 -1,562	-3%	-$28.2K	0.01%	1541
2023 Q1	$973K	Sell	52,556 -3,873	-7%	-$72.8K	﹤0.01%	1596
2022 Q4	$859K	Buy	56,429 +1,352	+2%	+$19.3K	﹤0.01%	1611
2022 Q3	$769K	Buy	55,077 +1,514	+3%	+$30.5K	﹤0.01%	1652
2022 Q2	$1.29M	Sell	53,563 -1,311	-2%	-$35.2K	0.01%	1289
2022 Q1	$1.69M	Sell	54,874 -5,877	-10%	-$211K	0.01%	1240
2021 Q4	$2.76M	Sell	60,751 -876	-1%	-$37.5K	0.01%	966
2021 Q3	$2.68M	Sell	61,627 -1,817	-3%	-$79K	0.01%	935
2021 Q2	$2.92M	Buy	63,444 +2,424	+4%	+$112K	0.01%	913
2021 Q1	$2.71M	Sell	61,020 -930	-2%	-$39K	0.01%	858
2020 Q4	$2.46M	Buy	61,950 +1,280	+2%	+$47.6K	0.01%	825
2020 Q3	$2.37M	Buy	60,670 +2,272	+4%	+$87K	0.02%	725
2020 Q2	$2.27M	Buy	58,398 +2,746	+5%	+$92.8K	0.02%	716
2020 Q1	$1.86M	Buy	55,652 +4,926	+10%	+$162K	0.02%	700
2019 Q4	$1.66M	Sell	50,726 -844	-2%	-$27.8K	0.01%	874
2019 Q3	$1.76M	Sell	51,570 -74	-0.1%	-$2.56K	0.02%	811
2019 Q2	$1.6M	Buy	51,644 +540	+1%	+$15.9K	0.01%	805
2019 Q1	$1.47M	Buy	51,104 +300	+0.6%	+$9.07K	0.01%	846
2018 Q4	$1.45M	Sell	50,804 -13,360	-21%	-$418K	0.02%	764
2018 Q3	$2.29M	Buy	64,164 +5,904	+10%	+$252K	0.02%	636
2018 Q2	$2.34M	Buy	58,260 +1,552	+3%	+$57.2K	0.02%	596
2018 Q1	$1.9M	Sell	56,708 -652	-1%	-$19.6K	0.02%	641
2017 Q4	$1.77M	Sell	57,360 -11,344	-17%	-$344K	0.02%	634
2017 Q3	$2M	Buy	68,704 +2,957	+4%	+$76K	0.03%	541
2017 Q2	$1.7M	Sell	65,747 -989	-1%	-$23.7K	0.03%	581
2017 Q1	$1.64M	Sell	66,736 -189	-0.3%	-$4.63K	0.03%	512
2016 Q4	$1.66M	Buy	66,925 +144	+0.2%	+$3.2K	0.03%	491
2016 Q3	$1.4M	Buy	66,781 +989	+2%	+$21.2K	0.03%	544
2016 Q2	$1.39M	Sell	65,792 -5,816	-8%	-$108K	0.03%	478
2016 Q1	$1.35M	Buy	71,608 +6,192	+9%	+$118K	0.03%	458
2015 Q4	$1.39M	Buy	65,416 +1,803	+3%	+$36.8K	0.03%	451
2015 Q3	$1.07M	Buy	63,613 +8,264	+15%	+$163K	0.03%	458
2015 Q2	$985K	Sell	55,349 -139	-0.3%	-$2.41K	0.03%	515
2015 Q1	$972K	Sell	55,488 -1,741	-3%	-$31.9K	0.03%	513
2014 Q4	$1.06M	Sell	57,229 -1,134	-2%	-$18.6K	0.03%	454
2014 Q3	$864K	Sell	58,363 -992	-2%	-$15.7K	0.03%	572
2014 Q2	$901K	Buy	59,355 +54	+0.1%	+$802	0.03%	492
2014 Q1	$1M	Buy	59,301 +162	+0.3%	+$2.65K	0.04%	420
2013 Q4	$1.01M	Buy	59,139 +7,691	+15%	+$134K	0.04%	392
2013 Q3	$781K	Sell	51,448 -600	-1%	-$8.58K	0.03%	446
2013 Q2	$723K	Buy	+52,048	New	+$687K	0.04%	410

Other funds holding NEOG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Cambridge Investment Research Advisors's NEOG Position: Q4 2024 in Review

Cambridge Investment Research Advisors sold out of Neogen (NEOG) in Q4 2024, closing a stake of 13,199 shares — an estimated $222K sold.

Cambridge Investment Research Advisors first reported a position in NEOG in Q2 2013 and held it in 46 quarters. The position peaked at $2.92M in Q2 2021. 343 funds tracked by Wall St. Rank hold NEOG as of Q4 2024.

Cambridge Investment Research Advisors reported no remaining Neogen position as of Q4 2024 after selling out during the quarter.
Cambridge Investment Research Advisors sold 13,199 Neogen shares in Q4 2024, an estimated $222K.
Cambridge Investment Research Advisors first reported a position in Neogen in Q2 2013 and held it in 46 quarters.
Cambridge Investment Research Advisors's Neogen position peaked at $2.92M in Q2 2021.
343 funds tracked by Wall St. Rank held Neogen as of Q4 2024.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.